Selection of Women Aged 50-64Yr for Bone Density Measurement

Journal of Clinical Densitometry

Volumn 16, Issue 4, 2013, Pages 570-578

  Leslie, William D ^a   Lix, Lisa M ^b   Johansson, Helena ^c   Oden, Anders ^c   McCloskey, Eugene ^d   Kanis, John A ^e  

^a UNIVERSITY OF MANITOBA   (Canada)

^b UNIVERSITY OF SASKATCHEWAN   (Canada)

^c Consulting Statistician ^*  (Sweden)

^d NORTHERN GENERAL HOSPITAL   (United Kingdom)

^e UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

Bone mineral density; Dual energy X ray absorptiometry; Fracture prediction; FRAX; Osteoporosis

Indexed keywords

PREDNISONE;

ADULT; ANTHROPOMETRY; AREA UNDER THE CURVE; ARTICLE; BODY WEIGHT; BONE DENSITOMETRY; BONE DENSITY; BONE MASS; CANADA; CHRONIC DRUG ADMINISTRATION; COHORT ANALYSIS; DATA BASE; DUAL ENERGY X RAY ABSORPTIOMETRY; EVIDENCE BASED PRACTICE; FEMALE; FEMUR NECK FRACTURE; FRAGILITY FRACTURE; HIP FRACTURE; HUMAN; MAJOR CLINICAL STUDY; OSTEOPOROSIS; PHYSICAL PERFORMANCE; POSTMENOPAUSE; PRACTICE GUIDELINE; PREDICTIVE VALUE; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; RISK ASSESSMENT; RISK FACTOR; SCREENING; SELF EVALUATION; SPINE; SPINE FRACTURE; TREATMENT INDICATION; WORLD HEALTH ORGANIZATION;

BONE MINERAL DENSITY; DUAL ENERGY X-RAY ABSORPTIOMETRY; FRACTURE PREDICTION; FRAX; OSTEOPOROSIS;

ABSORPTIOMETRY, PHOTON; BONE AND BONES; BONE DENSITY; FEMALE; HUMANS; INCIDENCE; MANITOBA; MIDDLE AGED; OSTEOPOROTIC FRACTURES; RISK ASSESSMENT; RISK FACTORS; ROC CURVE;

EID: 84887024653     PISSN: 10946950     EISSN: 15590747     Source Type: Journal    
DOI: 10.1016/j.jocd.2013.01.004     Document Type: Article

References (30)

1. NIH Consensus Development Panel Osteoporosis prevention, diagnosis, and therapy. JAMA 2001, 285:785-795.
2. Kanis J.A., Melton L.J., Christiansen C., et al. The diagnosis of osteoporosis. J Bone Miner Res 1994, 9:1137-1141.
3. Looker A.C., Wahner H.W., Dunn W.L., et al. Updated data on proximal femur bone mineral levels of US adults. Osteoporos Int 1998, 8:468-489.
4. Kanis J.A., McCloskey E.V., Johansson H., et al. A reference standard for the description of osteoporosis. Bone 2008, 42:467-475.
5. Lewiecki E.M., Gordon C.M., Baim S., et al. International Society for Clinical Densitometry 2007 Adult and Pediatric Official Positions. Bone 2008, 43:1115-1121.
6. Nelson H.D., Helfand M., Woolf S.H., Allan J.D. Screening for postmenopausal osteoporosis: a review of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med 2002, 137:529-541.
7. Nelson H.D., Haney E.M., Dana T., et al. Screening for osteoporosis: an update for the U.S. Preventive Services Task Force. Ann Intern Med 2010, 153:99-111.
8. U.S.Preventive Services Task Force Screening for osteoporosis in postmenopausal women: recommendations and rationale. Ann Intern Med 2002, 137:526-528.
9. Schousboe J.T., Ensrud K.E., Nyman J.A., et al. Universal bone densitometry screening combined with alendronate therapy for those diagnosed with osteoporosis is highly cost-effective for elderly women. J Am Geriatr Soc 2005, 53:1697-1704.
10. Kanis JA, on behalf of the World Health Organization Scientific Group. 2008 Assessment of osteoporosis at the primary health-care level. Technical Report: WHO Collaborating Centre for metabolic Bone Disease, University of Sheffield, UK. Available at: Accessed December 7, 2012. http://www.shef.ac.uk/FRAX.
11. Tosteson A.N., Melton L.J., Dawson-Hughes B., et al. Cost-effective osteoporosis treatment thresholds: the United States perspective. Osteoporos Int 2008, 19:437-447.
12. Tosteson A.N., Burge R.T., Marshall D.A., Lindsay R. Therapies for treatment of osteoporosis in US women: cost-effectiveness and budget impact considerations. Am J Manag Care 2008, 14:605-615.
13. Kanis J.A., Oden A., Johnell O., et al. The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women. Osteoporos Int 2007, 18:1033-1046.
14. Kanis J.A., McCloskey E.V., Johansson H., et al. Case finding for the management of osteoporosis with FRAX-assessment and intervention thresholds for the UK. Osteoporos Int 2008, 19:1395-1408.
15. Kanis J.A., McCloskey E., Johansson H., et al. FRAX with and without bone mineral density. Calcif Tissue Int 2012, 90:1-13.
16. Leslie W.D., Morin S., Lix L.M., et al. Fracture risk assessment without bone density measurement in routine clinical practice. Osteoporos Int 2012, 23:75-85.
17. Koh L.K., Sedrine W.B., Torralba T.P., et al. A simple tool to identify Asian women at increased risk of osteoporosis. Osteoporos Int 2001, 12:699-705.
18. Gourlay M.L., Powers J.M., Lui L.Y., Ensrud K.E. Clinical performance of osteoporosis risk assessment tools in women aged 67 years and older. Osteoporos Int 2008, 19:1175-1183.
19. Rud B., Jensen J.E., Mosekilde L., et al. Performance of four clinical screening tools to select peri- and early postmenopausal women for dual X-ray absorptiometry. Osteoporos Int 2005, 16:764-772.
20. Leslie W.D., MacWilliam L., Lix L., et al. A population-based study of osteoporosis testing and treatment following introduction of a new bone densitometry service. Osteoporos Int 2005, 16:773-782.
21. Leslie W.D., Caetano P.A., MacWilliam L.R., Finlayson G.S. Construction and validation of a population-based bone densitometry database. J Clin Densitom 2005, 8:25-30.
22. Hansen K.E., Binkley N., Christian R., et al. Interobserver reproducibility of criteria for vertebral body exclusion. J Bone Miner Res 2005, 20:501-508.
23. Roos N.P., Shapiro E. Revisiting the Manitoba Centre for Health Policy and Evaluation and its population-based health information system. Med Care 1999, 37:JS10-JS14.
24. Kozyrskyj A.L., Mustard C.A. Validation of an electronic, population-based prescription database. Ann Pharmacother 1998, 32:1152-1157.
25. Leslie W.D., Tsang J.F., Caetano P.A., Lix L.M. Effectiveness of bone density measurement for predicting osteoporotic fractures in clinical practice. J Clin Endocrinol Metab 2007, 92:77-81.
26. Leslie W.D., Lix L.M., Johansson H., et al. Independent clinical validation of a Canadian FRAX tool: fracture prediction and model calibration. J Bone Miner Res 2010, 25:2350-2358.
27. Fraser L.A., Langsetmo L., Berger C., et al. Fracture prediction and calibration of a Canadian FRAX tool: a population-based report from CaMos. Osteoporos Int 2011, 22:829-837.
28. Satagopan J.M., Ben-Porat L., Berwick M., et al. A note on competing risks in survival data analysis. Br J Cancer 2004, 91:1229-1235.
29. Steyerberg E.W. Clinical prediction models: a practical approach to development, validation, and updating 2008, Springer, New York, NY.
30. Nevitt M.C., Ettinger B., Black D.M., et al. The association of radiographically detected vertebral fractures with back pain and function: a prospective study. Ann Intern Med 1998, 128:793-800.